Home / BusinessCNBCBusinessCNBC·Jul 19, 2026·1 min readThe market for psychedelic drugs to treat mental health conditions gets a big buy signalEli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesCNBCBusinessJul 20, 2026 · 1 minTrump says Netanyahu won't be arrested in New York, pushing back on MamdaniCNBCRio TimesBusinessJul 20, 2026 · 1 minBrazil’s Pix Goes Global as US$660B Monthly GiantRio TimesMarketWatchBusinessJul 20, 2026 · 1 minAs Micron’s stock rebounds, Morgan Stanley says investors shouldn’t get spooked by the pastMarketWatchBuenos Aires TimesBusinessJul 20, 2026 · 1 minMilei opens door to electric cars as Musk's Tesla firms up arrival plansBuenos Aires Times
CNBCBusinessJul 20, 2026 · 1 minTrump says Netanyahu won't be arrested in New York, pushing back on MamdaniCNBC
MarketWatchBusinessJul 20, 2026 · 1 minAs Micron’s stock rebounds, Morgan Stanley says investors shouldn’t get spooked by the pastMarketWatch
Buenos Aires TimesBusinessJul 20, 2026 · 1 minMilei opens door to electric cars as Musk's Tesla firms up arrival plansBuenos Aires Times